Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

The purpose of this study was to evaluate the safety and efficacy of peginesatide in the maintenance treatment of anemia in participants on dialysis.

Phase 3

Affymax

Takeda

Epoetin Alfa